Mark Sieczkarek
Overview
Mark Sieczkarek received an average of $1M in total compensation, including $268K in salary, at NovaBay Pharmaceuticals from 2015 to 2018.
Source: SEC filings on April 19, 2019, April 18, 2018, and April 21, 2017.
Related executives
We found 12 more executives who work or worked at NovaBay Pharmaceuticals.
Justin Hall
NovaBay Pharmaceuticals
Chief Executive Officer
Andrew Jones
NovaBay Pharmaceuticals
Chief Financial Officer
Audrey Kunin
NovaBay Pharmaceuticals
Chief Product Officer
Wang Xu
NovaBay Pharmaceuticals
Senior Manager and Controller
Jason Raleigh
NovaBay Pharmaceuticals
Chief Financial Officer
John McGovern
NovaBay Pharmaceuticals
Chief Executive Officer
Lewis Stuart
NovaBay Pharmaceuticals
Former Chief Commercial Officer
Thomas Paulson
NovaBay Pharmaceuticals